Two-year safety and effectiveness of the platinum chromium everolimus-eluting stent for the treatment of small vessels and longer lesions

Paul S Teirstein, Ian T Meredith, Robert L Feldman, Charles A Rabinowitz, Louis A Cannon, Tommy C Lee, Joseph Dens, Christophe L Dubois, Michael R Mooney, Vincent J Pompili, Shigeru Saito, Dominic J Allocco, Keith D Dawkins, Gregg W Stone

Research output: Contribution to journalArticleResearchpeer-review

21 Citations (Scopus)


OBJECTIVES: To report 1- and 2-year clinical outcomes of patients receiving platinum chromium everolimus-eluting stents (PtCr-EES) in the prospective, single-arm PLATINUM small vessel (SV) and long lesion (LL) studies. BACKGROUND: Small vessel diameter and long lesion length are independently associated with increased risk of adverse cardiac events after drug-eluting stent implantation. METHODS: The PLATINUM SV study enrolled 94 patients with coronary artery lesions in vessels >/=2.25 mm to 24 to /=2.50 to
Original languageEnglish
Pages (from-to)207 - 215
Number of pages9
JournalCatheterization and Cardiovascular Interventions
Issue number2
Publication statusPublished - 2015

Cite this